Antimicrobial Resistance (AMR) is one of the threats, hurtling the South Asia region towards a medical dark age where a simple scrape or a common cold could once again become a death sentence, and the region is ground zero for this silent invasion. Although the global community is often drawn to the abrupt geopolitical changes or the immediate outbreak of viruses, a much more dangerous crisis is rooted in the South Asian hospitals, farms, and river systems. We are on the edge of a post-antibiotic era, a reversion to a period when a scrape on the skin, a routine cesarean section, or a common cold respiratory infection is a death sentence.
South Asia, with more than two billion people, has unwillingly turned into the epicenter of drug-resistant infections globally. In Pakistan, India, Bangladesh, and Nepal, the magic pills that characterized 20th-century medicine are quickly becoming ineffective. With an unregulated pharmaceutical market, agricultural abuse of huge proportions, and unstable sanitation systems, AMR is no longer a hypothetical threat in the future. It is a current systemic failure that is threatening to roll back decades of medical advances, making routine treatment of tuberculosis, malaria, and neonatal sepsis extremely ineffective.
The Human Toll: When Miracles Fail
The neonatal intensive care units (NICUs) in the region of South Asia provide a good way to see the sheer size of the AMR crisis in this area. Neonatal sepsis, a life-threatening systemic infection that happens during the first month of life, is ten times more prevalent in India than in high-income nations. The fatality rate of such infants can reach up to 50 percent in ICUs. Gram-negative pathogens are the most common offenders, and they have adapted to resist our most potent antibiotics. Infants who are born completely healthy are dying of hospital-acquired superbugs within a few days after their birth. A similar crisis is underway in Pakistan and Bangladesh, but in this case, the crisis takes place silently in the overcrowded state hospitals, where the lack of diagnostic capabilities frequently leads to the situation where the resistant pathogen is detected only when it is too late.
Outside the NICU, three of the oldest enemies of the region are staging a strong resurgence: Tuberculosis (TB), Malaria, and Typhoid. TB has traditionally been a South Asian disease, but now we are experiencing a nightmare scenario of Multi-Drug-Resistant (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) replacing treatable bacterial strains. The management of these resistant strains is tedious, extremely toxic, and economically disastrous to the families.
Likewise, the Artemisinin-based Combination Therapies (ACTs), which are the first line of defense against malaria, are slowly being overcome by resistance to cross international borders, thus reversing the gains made in eradicating malaria in the past two decades. In the meantime, Pakistan is still fighting the spread of Extensively Drug-Resistant (XDR) Typhoid, which has evolved to live through almost all the available oral antibiotics, leaving intravenous drugs of last resort as the only and very costly choice.
The numbers are astounding even in the less populated, mountainous areas of Nepal. Recent reports show that AMR was a major cause of death of almost 20,000 people in Nepal within a year. These are not merely statistics, but they are a display of the disaster of our medical safety nets.
The Agricultural Catalyst and Environmental Vectors
There is a widespread misconception that AMR is just a clinical issue that is the result of overprescription of antibiotics by physicians or self-medication by patients. In reality, human medicine is only half the story. Agricultural and other sectors are massive, unregulated drivers of this silent pandemic.
In Bangladesh and Pakistan, the unprescribed and prophylactic use of antimicrobials is highly important to booming poultry and aquaculture industries. Critically important drugs to human medicine, like Colistin, are regularly added to animal feed to stimulate growth and prevent infection in overcrowded farms. When we eat this meat, or when the runoff of the agriculture is deposited into the local water system, we are eating the resistant bacteria and the genetic code that allows them to survive.
This brings us to the environmental vector. The AMR of waterborne diseases is a pivotal multiplier of the crisis. An example is India, which treats 28 percent of its urban wastewater. The remaining 72 percent is discharged into rivers and lakes without treatment, and this releases a toxic cocktail of antibiotic residues, resistant microbes, and resistance genes directly into the natural water bodies. The rivers such as the Ganges, the Indus, and the Brahmaputra are turning into large reservoirs of superbugs. When the populations depend on such water sources to drink, bathe, and irrigate, a self-perpetuating mechanism of infection and resistance increases in the whole ecosystem.
The Economic Avalanche of 2030
The cost of doing nothing is not just quantified in human lives, but in macroeconomic destruction. The World Bank projects that, globally, up to 24 million people could fall into extreme poverty by 2030 as a direct result of antimicrobial resistance. The economic impact is due to the skyrocketing healthcare expenses, the need to use second and third-line antibiotics, which are costly, and the long-term hospital stays.
By the year 2030, the losses in the global Gross Domestic Product (GDP) associated with AMR are estimated to be between 1 trillion and 3.4 trillion per year. South Asia will bear a disproportionate share of this burden. In India alone, it is projected that there will be between 0.9 and 1.4 million deaths related to AMR every year by the end of the decade. To the already post-pandemic recoveries, crippling debt, and climate-induced disasters in the economies of Pakistan, Bangladesh, India, and Nepal, the extra weight of an untreatable disease landscape will be catastrophic.
AMR is set to drain the national health budgets, emaciate the labor force through the rising morbidity, and bring down the backbone of modern medical treatment, such as cancer chemotherapy, organ transplants, and joint replacements, which are all dependent on the efficacy of prophylactic antibiotics.
The "One Health" Imperative: A Regional Strategy
A pathogen that is carrying a resistance gene does not recognize the Wagah border, and neither does it acknowledge the Teesta River disputes. AMR is inherently a transnational menace by its very nature, which cannot be limited by national policies that are isolated and siloed. The only way out is a strong, regionally-based, “One Health” approach.
The One Health framework acknowledges that the health of humans, animals, and the sustainability of the environment are inseparable. To prevent a return to the pre-penicillin era, South Asian governments must adopt a synchronized, multi-sectoral strategy:
Agricultural Reform and Blanket Bans: We need to impose and vigorously implement bans on the use of critically important human antibiotic drugs in livestock and aquaculture in the region. Bangladesh has already started to show the effectiveness of combining the veterinary and agricultural sectors to solve the problem of the indiscriminate use of antibiotics in animal husbandry, a model that has to be extended to the region.
Integrated Surveillance Networks: We need a unified South Asian AMR surveillance grid that will monitor resistance patterns, not only in hospital ICUs, but also in abattoirs, poultry farms, and urban wastewater systems. The first step towards intercepting these pathogens is to understand the environmental flow of these pathogens.
Empowering Preventive Medicine and Vaccines: Any infection avoided is an antibiotic conserved. We need to put a lot of effort into sanitation, clean water systems, and overall immunization. Nepal has given an exemplary blueprint on this. With the introduction of the Typhoid Conjugate Vaccine (TCV), Nepal cut by an incredible 79% in two years the number of blood culture-confirmed cases of typhoid. Scaling up TCV and Pneumococcal Conjugate Vaccines (PCV) in South Asia on a large scale would prevent millions of infections, which would significantly decrease the need to use antibiotics.
Strict Clinical Stewardship: The days of purchasing broad-spectrum antibiotics over the counter, as easily as buying a loaf of bread, must end. Governments must implement stringent prescription-only legislation and huge publicity campaigns to sensitize the people on the risks of self-medication and not completing antibiotic courses.
Avoiding the Pre-Penicillin Era
We are currently sleepwalking on a cliff edge. Unless South Asia takes a different path in its current trajectory, the post-antibiotic era will not come with a dramatic cinematic event; it will come silently. It will come at a time when an ordinary surgery will be too dangerous to carry out. It will come when a child has their knee scraped and this results in an uncontrollable fatal infection.
The Antimicrobial Resistance silent pandemic needs to be tackled by dissolving institutional silos. It requires Ministers of Health to be at the same table with Ministers of Agriculture and Water Resources. It needs the political will of Pakistan, India, Bangladesh, and Nepal to put biological security first before agricultural productivity and profits in pharmaceuticals.
The financial resources that are needed to adopt the One Health strategy are high, but the payback is apparent. It has been estimated throughout the world that a comprehensive set of One Health interventions can prevent a cost of 7.7 trillion by 2035. The science is clear, the economics is undeniable, and the moral imperative is absolute. We possess the means to tip the scales back in the favor of humanity against the superbugs, but the time to do so is running out. South Asia needs to come together in order to ensure the effectiveness of our best medical success, or risk throwing the new generation into the dark ages of infectious disease. 
Leave a Reply